Skip to main content

Day: April 13, 2022

PRESS RELEASE DATED 13 APRIL 2022 RELATING TO THE AVAILABILITY OF THE OFFER DOCUMENT AND DOCUMENT PRESENTING INFORMATION RELATING IN PARTICULAR TO THE LEGAL, FINANCIAL AND ACCOUNTING CHARACTERISTICS OF VINCI CONCESSIONS AND EIFFAGE

Vélizy-Villacoublay and Nanterre, 13 April 2022 5:00 pm This press release does not constitute an offer to purchase securities. PRESS RELEASE DATED 13 APRIL 2022 RELATING TO THE AVAILABILITY OF THE OFFER DOCUMENT AND DOCUMENT PRESENTING INFORMATION RELATING IN PARTICULAR TO THE LEGAL, FINANCIAL AND ACCOUNTING CHARACTERISTICS OF VINCI CONCESSIONS AND EIFFAGE IN CONNECTION WITH THE SIMPLIFIED PUBLIC TENDER OFFER FOR THE SHARES OF SOCIETE MARSEILLAISE DU TUNNEL PRADO CARENAGE INITIATED BY VINCI CONCESSIONS AND EIFFAGE  PRESENTED BY  PORTZAMPARC (BNP PARIBAS)    PRESENTING AND GUARANTEEING INSTITUTION BID PRICE: € 27.00 per share of SOCIETE MARSEILLAISE DU TUNNEL PRADO CARENAGE DURATION OF THE OFFER: 15 trading days The timetable for the simplified tender offer (the “Offer”) will be determined by the Autorité des marchés financiers...

Continue reading

Decision on the approval of circulars for a mandatory non – competitive official offer in order to remove the shares of Linas, AB from trading on a regulated market

  In April 12, 2022, Decisions of The Financial Market Supervision Committee of the Bank of Lithuania was approved:circular for a mandatory non – competitive official offer in order to remove the shares of Linas, AB from trading on a regulated market (hereinafter – OO for delisting); circular for a mandatory non – competitive official offer on the 2006 acquired control of Linas, AB (hereinafter – OO for obligation implement)The Official Offeror –Verslo dizainas, UAB, legal entity code 302529076, whose registered headquarters is at Savanorių pr. 192, Kaunas, implementing the decision, made on 25 May, 2021 by extraordinary General Meeting of Shareholders of Linas, AB (hereinafter – The Company),  i to remove the shares of Linas, AB from trading on a regulated market and suspension of public offer of shares (hereinafter...

Continue reading

Millicom (Tigo) notice of first quarter 2022 results and video conference

Millicom (Tigo) notice of first quarter 2022 results and video conference Luxembourg, April 13, 2022 – Millicom expects to announce its first quarter 2022 results on April 28, 2022 at approximately 12:00 (Stockholm) / 11:00 (London) / 06:00 (Miami) via a press release. Millicom is planning to host a video conference for the global financial community on April 28, 2022 at 14:00 (Stockholm) / 13:00 (London) / 08:00 (Miami). Registration for the interactive event is required at the following link. After registering, you will receive a confirmation email containing details about joining the video conference. Participants who wish to ask a question during the live event must notify the Investor Relations team via email to investors@millicom.com after the start of the event. Participants may also join the conference in listen-only mode by dialing...

Continue reading

Form 8.3 – Brand Architekts Group plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1.        KEY INFORMATION  (a)        Full name of discloser: Peter & Jane Squire(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Brand Architekts Group plc(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)        Date position...

Continue reading

Biofrontera Inc. Announces FDA Approval of Biofrontera Pharma GmbH as a Contract Laboratory for Ameluz®

Significantly Improves Manufacturing Efficiency, Quality Control and Supply Reliability WOBURN, Mass., April 13, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the U.S. Food and Drug Administration (FDA) has approved Biofrontera Pharma’s cGMP laboratory in Leverkusen, Germany, as a contract laboratory for batch control and stability testing of Ameluz® (aminolevulinic acid hydrochloride gel, 10%). This recognition enables significant improvements in product manufacturing efficiency, quality control and reliability of supply. The FDA cleared Biofrontera Pharma GmbH’s laboratory to operate a method of impurity testing, which is a critical component of the gel’s stability assurance. The clearance enables part...

Continue reading

EDP Renewables and Meta Expand Partnership Through Long-Term Contract for a New Texas Solar Park

The agreement will enable the continued development and eventual construction of a Texas solar park that will annually power the equivalent of more than 37,000 average homes.EDP Renewables Logo Logo for EDP RenewablesHouston, Texas, April 13, 2022 (GLOBE NEWSWIRE) — EDP Renewables SA (EDPR), through its fully owned subsidiary EDP Renewables North America LLC (EDPR NA), and Meta (NYSE: FB) have executed a long-term power purchase agreement (PPA) for 156 megawatts (MW) at the 240-MW Cattlemen Solar Park in Milam County, located in central Texas. This contract is a part of the announcement EDPR issued on April 11, 2022. EDP Renewables North America developed and will construct, own, and operate Cattlemen Solar Park, which has an estimated capital investment of approximately $280 million and is anticipated to be operational in...

Continue reading

Medigus to Invest in a Deep Energy Tech Company

New investment targets improving and optimizing the global water, oil, and gas transportation infrastructure through cutting-edge technology that reduces pump energy requirements Tel Aviv, Israel, April 13, 2022 (GLOBE NEWSWIRE) —  Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that it has signed an agreement to invest in ABI Energy Ltd. (ABI), a deep-tech company developing cutting-edge devices that optimize fluid transportation to improve the global water, oil, and gas pipeline transportation infrastructure. Following this recent investment, Medigus will hold approx. 19.17%. ABI, which will soon be rebranded as Laminera, technology-driven solutions are designed to improve and optimize existing...

Continue reading

Logansport Financial Corp. Reports Net Earnings for the Quarter Ended March 31, 2022

LOGANSPORT, Ind., April 13, 2022 (GLOBE NEWSWIRE) — Logansport Financial Corp., (OTCBB, LOGN), parent company of Logansport Savings Bank, reported net earnings for the quarter ended March 31, 2022 of $783,000 or $1.28 per diluted share, compared to earnings in 2021 of $934,000 or $1.52 per diluted share. The Dividends paid to shareholders were $0.40 per share in the first quarter of 2022. Total loans were $143.4 million on March 31, 2022 compared to $139.5 million on December 31, 2021. Deposits were $218.7 million on March 31, 2022 compared to $216.6 million on December 31, 2021. Total assets on March 31, 2022 were $244.9 million compared to $247.7 million on December 31, 2021. The statements contained in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of...

Continue reading

Lotus Bio-Technology Development Corp. (OTC: LBTD) (“LBTD”) Announces Entering Into a Binding Letter of Intent

Lotus Bio-Technology Development Corp. (OTC: LBTD) (“LBTD”) Announces Entering Into a Binding Letter of Intent With AMT Industries To Acquire Up To 100% of Little Jupiter Gold Project – Nevada, Vancouver BC, April 13, 2022 (GLOBE NEWSWIRE) — Point Roberts, Washington – Lotus Bio-Technology Development Corp. (OTC: LBTD) (“LBTD”) Announces Entering Into a Binding Letter of Intent With AMT Industries To Acquire Up To 100% of Little Jupiter Gold Project – Nevada, USA About the Little Jupiter Gold Project and Historical Resource The Little Jupiter Gold Project is located in Pershing County, Nevada, within the Sierra Mining District. It is located within a high-grade gold and silver zone tested by the USGS (United States Geological Survey), with 35 unpatented mining claims. The project is supported by excellent infrastructure...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.